Carine Lefevre
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-Skewed Hematopoiesis in Sickle Cell Anemia.
Journal: American journal of hematology
Published: February 17, 2026
IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-skewed Hematopoiesis in Sickle Cell Anemia.
Journal: Research square
Published: November 24, 2025
MMS22L is a novel key actor of normal and pathological erythropoiesis.
Journal: HemaSphere
Published: November 04, 2024
Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation.
Journal: Nature communications
Published: December 07, 2022
Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: a novel role through transferrin receptors.
Journal: Experimental hematology
Published: January 13, 2021
Myotonic dystrophy kinase-related CDC42-binding kinase α, a new transferrin receptor type 2-binding partner, is a regulator of erythropoiesis.
Journal: American journal of hematology
Published: October 01, 2020
The epigenetic regulator RINF (CXXC5) maintains SMAD7 expression in human immature erythroid cells and sustains red blood cells expansion.
Journal: Haematologica
Published: June 18, 2020
Comprehensive proteomic analysis of murine terminal erythroid differentiation.
Journal: Blood advances
Published: February 11, 2020
A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome.
Journal: Science translational medicine
Published: September 27, 2018
Dyserythropoiesis of myelodysplastic syndromes.
Journal: Current opinion in hematology
Published: January 11, 2017
Erythropoietin and IGF-1 signaling synchronize cell proliferation and maturation during erythropoiesis.
Journal: Genes & development
Published: December 19, 2015
Last Updated: 09/26/2026